Georgetown University Department of Family Medicine, Research Division
Washington D.C., District of Columbia, 20009, United States
NCT Number: NCT00760851
The purpose of this study is to determine the effectiveness of probiotics (popularly referred to as 'live active culture' or 'good bacteria') in preventing illnesses and consequent absences from school/daycare centers of children two to four years old that attend daycare at least 3 days per week. Two yogurt drinks will be administered, one containing a specific strain of probiotic, Bb-12. It is hypothesized that children receiving the Bb-12 drink will experience fewer illnesses and absences from daycare.
In this study, participants will be asked to:
1. Give their child 4 oz. of the test yogurt each day for 90 days 2. Keep a daily diary of their child's health 3. Collect 3 stool samples from their child at the start, middle, and end of the study 4. Speak with research personnel on a bi-weekly basis regarding their child's health 5. Ensure that their child to consume any yogurts or probiotic-containing products for 110 days of the study
Looking for future studies?
Notify Me2 year–4 year
All sexes
Interventional
Phase 3
Washington D.C., District of Columbia, 20009, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10^9 CFU Bb-12 per 4 oz yogurt
Other names: Bifidobacterium lactis 12
yogurt identical to intervention yogurt, only without Bb-12 added.
Time frame: 90 days
Time frame: 90
Georgetown University
Other
Study to Investigate the Potential of Probiotics II
Acronym: SIPPY II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT04380701
COVID-19, Coronaviridae Infections
Berlin, Germany
View Trial DetailsNCT04649957
COVID-19, Coronaviridae Infections
Derby, United Kingdom
View Trial DetailsNCT04591873
COVID-19, Coronaviridae Infections
Taipei, Taiwan
View Trial Details